Elvina Giyazitdinova
Elvina Giyazitdinova publishes mostly in Neurology, Immunology and Physiology, on topics such as Cerebrovascular and genetic disorders, Parkinson's Disease Mechanisms and Treatments and Atherosclerosis and Cardiovascular Diseases.
- World rank
- #5,832,921 of 7,710,434 ranked researchers
- Rank in Uzbekistan
- #1,370 of 3,371
- Works
- 20
- Citations
- 4
- Citations per work
- 0.2
What does Elvina Giyazitdinova research?
Elvina Giyazitdinova's work is mostly in Medicine (34%), Neuroscience (11%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1047.8%
- Health Sciences734.1%
- Medicine734.1%
- Life Sciences418.1%
- Neuroscience211.3%
- Immunology and Microbiology16.8%
- 1Neurology20% of their works
- 2Immunology7% of their works
- 3Physiology7% of their works
- 4Neurology7% of their works
- 5Endocrinology, Diabetes and Metabolism7% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Cerebrovascular and genetic disorders
- Parkinson's Disease Mechanisms and Treatments
- Atherosclerosis and Cardiovascular Diseases
- Nuclear Receptors and Signaling
- Neurological diseases and metabolism
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Dementia and Cognitive Impairment Research
- Cerebrovascular and Carotid Artery Diseases
Which keywords describe Elvina Giyazitdinova's research?
The keywords of their largest research topics: Neurodegeneration, Dopaminergic Neurons, Parkinson's Disease, Atherosclerosis, CADASIL, Inflammation, Neuroimaging and Notch3 receptor.
- Pantothenate Kinase
- Nurr1
- Mild Cognitive Impairment
- Immune Response
- Carotid Artery Stenosis
- Brain Iron Accumulation
- a-Synuclein
- Notch3 receptor
- Inflammation
- Atherosclerosis
- Dopaminergic Neurons
- Neurodegeneration
- Parkinson's Disease
- CADASIL
- Neuroimaging
- Genetic Risk Factors
- Alzheimer's Disease
- Cardiovascular Disease
- Endarterectomy
- Metabolic Syndrome
- NR4A2
- Oxidized LDL
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Neurodegeneration73 topics
- Dopaminergic Neurons52 topics
- Parkinson's Disease52 topics
- Atherosclerosis42 topics
- CADASIL41 topic
- Inflammation42 topics
- Neuroimaging42 topics
- Notch3 receptor41 topic
- Genetic Risk Factors31 topic
- a-Synuclein31 topic
- Alzheimer's Disease21 topic
- Brain Iron Accumulation21 topic
- Cardiovascular Disease21 topic
- Carotid Artery Stenosis21 topic
- Endarterectomy21 topic
- Immune Response21 topic
- Metabolic Syndrome21 topic
- Mild Cognitive Impairment21 topic
- NR4A221 topic
- Nurr121 topic
- Oxidized LDL21 topic
- Pantothenate Kinase21 topic
Where does Elvina Giyazitdinova work?
Elvina Giyazitdinova's main affiliation in the publication record is Tashkent Medical Academy, Uzbekistan.
How many publications and citations does Elvina Giyazitdinova have?
OpenAlex counts 20 works and 4 citations for Elvina Giyazitdinova, an h-index of 1, ranking #5,832,921 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Elvina Giyazitdinova. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.